ICU Medical, Inc. (ICUI)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1,271 | 1,316 | 2,280 | 2,259 | 2,382 | 2,230 | 2,159 | 2,187 |
| Operating profit | $m | 107 | 109 | ||||||
| Net profit | $m | 87 | 103 | -74 | -30 | -118 | 1 | 30 | 218 |
| EPS reported | $ | 0.03 | 1.18 | ||||||
| Operating cashflow per share | $ | 7.30 | 9.45 | ||||||
| Capex per share | $ | 3.57 | 3.34 | ||||||
| FCF per share | $ | 3.73 | 6.11 | ||||||
| Free cash flow | $m | 92 | 153 | ||||||
| Net debt | $m | 1,037 | 933 | ||||||
| Book value equity | $m | 2,124 | 2,152 | ||||||
| Book value per share | $ | 85.28 | 85.92 | ||||||
| Number of shares | m | 24.9 | 25.04 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | 139.79 | ||||||
| P/B LTM | x | 1.66 | 1.63 | ||||||
| P/S LTM | x | 1.58 | 1.63 | ||||||
| P/FCF LTM | x | 38.29 | 23.00 | ||||||
| EV/EBITDA LTM | x | 14.09 | 15.45 | ||||||
| EV/Sales LTM | x | 2.06 | 2.57 | ||||||
| Earnings Yield LTM | % | +0.02% | +0.72% | ||||||
| FCF Yield | % | +2.61% | +4.35% | ||||||
| Quality | |||||||||
| ROE | % | +0.03% | +1.41% | ||||||
| ROIC | % | +0.69% | -21.74% | ||||||
| Operating margin | % | +4.80% | +5.04% | ||||||
| Gross margin | % | +36.76% | +37.56% | ||||||
| FCF/Sales | % | +4.12% | +7.08% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -6.38% | -9.35% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | -26.36% | +22.60% | ||||||
| Operating Profit Growth | % | +148.93% | +153.13% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.07 | 0.12 | ||||||
| Net Debt/EBITDA | x | 3.32 | 3.27 | ||||||
| EBIT/Net interest | x | 1.01 | 1.31 | ||||||
| Net debt/market cap | % | +38.25% | +26.92% | ||||||
| Net debt/Equity | x | 0.49 | 0.43 | ||||||
| Gross debt/equity | x | 0.66 | 0.59 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free